These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 19819722)
1. Apolipoprotein A-I inhibits chemotaxis, adhesion, activation of THP-1 cells and improves the plasma HDL inflammatory index. Wang L; Chen WZ; Wu MP Cytokine; 2010 Feb; 49(2):194-200. PubMed ID: 19819722 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice. Yan YJ; Li Y; Lou B; Wu MP Life Sci; 2006 Jun; 79(2):210-5. PubMed ID: 16574162 [TBL] [Abstract][Full Text] [Related]
3. [Effect of Huoxue injection on oxidized low-density lipoprotein induced activation of human umbilical vein endothelial cells]. Zhu LQ; Wang SR; Zhao MJ; Cui W; Niu FL Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1617-21. PubMed ID: 18837329 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zinc. Kojima C; Kawakami A; Takei T; Nitta K; Yoshida M J Pharmacol Exp Ther; 2007 Dec; 323(3):855-60. PubMed ID: 17878405 [TBL] [Abstract][Full Text] [Related]
5. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275 [TBL] [Abstract][Full Text] [Related]
6. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Ting HJ; Stice JP; Schaff UY; Hui DY; Rutledge JC; Knowlton AA; Passerini AG; Simon SI Circ Res; 2007 Feb; 100(3):381-90. PubMed ID: 17234968 [TBL] [Abstract][Full Text] [Related]
7. Neutrophils activation can be diminished by apolipoprotein A-I. Liao XL; Lou B; Ma J; Wu MP Life Sci; 2005 Jun; 77(3):325-35. PubMed ID: 15878359 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of VCAM-1 expression in endothelial cells by reconstituted high density lipoproteins. Calabresi L; Franceschini G; Sirtori CR; De Palma A; Saresella M; Ferrante P; Taramelli D Biochem Biophys Res Commun; 1997 Sep; 238(1):61-5. PubMed ID: 9299452 [TBL] [Abstract][Full Text] [Related]
9. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Hiraoka M; Nitta N; Nagai M; Shimokado K; Yoshida M Life Sci; 2004 Jul; 75(11):1333-41. PubMed ID: 15234191 [TBL] [Abstract][Full Text] [Related]
10. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant. Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437 [TBL] [Abstract][Full Text] [Related]
12. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA J Am Coll Cardiol; 2009 Mar; 53(11):962-71. PubMed ID: 19281927 [TBL] [Abstract][Full Text] [Related]
13. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory functions of apolipoprotein A-I and high-density lipoprotein are preserved in trimeric apolipoprotein A-I. Murphy AJ; Hoang A; Aprico A; Sviridov D; Chin-Dusting J J Pharmacol Exp Ther; 2013 Jan; 344(1):41-9. PubMed ID: 23033374 [TBL] [Abstract][Full Text] [Related]
15. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha. Qin S; Liu T; Kamanna VS; Kashyap ML Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455 [TBL] [Abstract][Full Text] [Related]
16. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. Shepherd J; Packard CJ; Patsch JR; Gotto AM; Taunton OD J Clin Invest; 1979 May; 63(5):858-67. PubMed ID: 221531 [TBL] [Abstract][Full Text] [Related]
17. High-density lipoproteins (HDL) inhibit endotoxin-induced leukocyte adhesion on endothelial cells in rats: effect of the acute-phase HDL. Thaveeratitham P; Khovidhunkit W; Patumraj S Clin Hemorheol Microcirc; 2007; 36(1):1-12. PubMed ID: 17211057 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Smythies LE; White CR; Maheshwari A; Palgunachari MN; Anantharamaiah GM; Chaddha M; Kurundkar AR; Datta G Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1538-48. PubMed ID: 20219948 [TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
20. Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells in vitro. Liu GX; Ou DM; Li LX; Chen LX; Huang HL; Liao DF; Tang CS Acta Pharmacol Sin; 2002 Jun; 23(6):516-22. PubMed ID: 12060525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]